Glaxosmithkline Pharmaceuticals Ltd News
GSK Pharmaceuticals Q1 results: Net profit jumps 38% to Rs 182.33 crore
The company had posted a consolidated net profit of Rs 132.25 crore in the same quarter last fiscal, GlaxoSmithKline Pharmaceuticals (GSK Pharma) said in a regulatory filing
 "GSK Pharmaceuticals Q1 results: Net profit jumps 38% to Rs 182.33 crore")
GSK Pharma Q4 results: Profit rises 45% on growth in NLEM drugs, vaccines
The board has recommended a dividend of Rs 32 per equity share on face value of Rs 10 each for the year ended 31 March 2024, subject to approval of members at 99th Annual General Meeting
 "GSK Pharma Q4 results: Profit rises 45% on growth in NLEM drugs, vaccines")
GSK Pharma Q4 results: Net profit up 46% at Rs 194.48 cr on higher sales
GlaxoSmithKline Pharmaceuticals Ltd on Friday reported a 46 per cent increase in consolidated net profit at Rs 194.48 crore in the fourth quarter ended March 31, on the back of higher sales. The company had posted a net profit of Rs 133.43 crore in the corresponding quarter of the previous fiscal, GlaxoSmithKline Pharmaceuticals (GSK Pharma) said in a regulatory filing. Consolidated revenue from operations in the quarter under review stood at Rs 929.8 crore as against Rs 787.45 crore in the year-ago period, it added. Total expenses in the fourth quarter were higher at Rs 691.41 crore as compared to Rs 635.54 crore in the same period a year ago. The board has recommended a dividend of Rs 32 per equity share on the face value of Rs 10 each for the year ended March 31, subject to approval of members at upcoming annual general meeting, the company said. For the fiscal ended March 31, 2024 net profit was at Rs 589.96 crore as compared to Rs 610.69 crore in the preceding year, the compa
